Introduction Diabetic retinopathy (DR) is one of the most frequent microvascular
complications of diabetes that can lead to blindness. Laser treatment has been the gold …

Importance Systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF)
is a matter of debate and regular updates are necessary. Objective To evaluate systemic …

Background To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal
ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand …

Adverse renal effects of systemic vascular endothelial growth factor (VEGF) inhibitor
treatment are well documented. We aimed to identify associations between intravitreal VEGF …

Vascular endothelial growth factor (VEGF) inhibitors, ranibizumab, aflibercept, and
pegaptanib are approved treatments for certain eye diseases that occurs especially in the …

Aims To identify the association between ranibizumab and risk of stroke and acute
myocardial infarction (AMI) in patients with exudative age-related macular degeneration …

Introduction: Intravitreal anti-VEGF is the most effective therapy for wet AMD, although
systemic effects on the endothelium cannot be excluded. Areas covered: The purpose of this …

This retrospective cohort study aimed to assess the systemic effects of three commonly
available anti-vascular endothelial growth factor intravitreal injections in patients with …

Objectives To evaluate whether intravitreal injections (IVI) of anti-vascular endothelial
growth factor (anti-VEGF) in neovascular age-related macular degeneration (nAMD) patients …

Real-World Data (RWD) is commonly defined as data collected in a non-randomized
controlled trial setting, highlighting the representativeness of RWD for an actual diagnosis …